1 – 10 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab
(
- Contribution to journal › Article
- 2023
-
Mark
Childhood tuberous sclerosis complex in southern Sweden: A paradigm shift in diagnosis and treatment.
(
- Contribution to journal › Article
- 2022
-
Mark
Structural association between heterotopia and cortical lesions visualized with 7T MRI in patients with focal epilepsy
(
- Contribution to journal › Article
-
Mark
Satisfaction and seizure outcomes of epilepsy surgery in tuberous sclerosis : A Swedish population-based long-term follow-up study
(
- Contribution to journal › Article
- 2021
-
Mark
Validation of the Swedish version of the Beliefs about Medicines Questionnaire, based on people with epilepsy
(
- Contribution to journal › Article
-
Mark
Widespread skeptic attitudes among people with epilepsy toward generic antiseizure drugs – A Swedish survey study
(
- Contribution to journal › Article
-
Mark
Physicians' attitudes toward generic substitutions of antiseizure drugs in epilepsy
(
- Contribution to journal › Article
- 2020
-
Mark
Evidence-based Anti-seizure Monotherapy in Newly Diagnosed Epilepsy: a New Approach
(
- Contribution to journal › Article
-
Mark
Rituximab in multiple sclerosis at general hospital level
(
- Contribution to journal › Article
-
Mark
Tensor-valued diffusion MRI differentiates cortex and white matter in malformations of cortical development associated with epilepsy
(
- Contribution to journal › Article